Scilex’s premise is simple: the Palo Alto company generates revenue by acquiring, developing, and commercializing non-opioid ...

ZTlido® is a registered trademark owned by Scilex Pharmaceuticals Inc., a wholly-owned subsidiary of Scilex Holding Company. Gloperba® is the subject of an exclusive, transferable license to Scilex ...

Pharmaceutical and biotech stocks often are seen as steady and safe options for investors for one particular reason. Patients ...

Asthma affects more than 260M people worldwide and nearly 28M people in the U.S. alone, where, on average, 10 people die from attacks of the chronic disease each day.

Type C meeting feedback confirms pre-clinical and clinical data are adequate for an NDA submission and potential approval of AKANTIOR® in the US In the UK, SIFI submitted a Marketing Authorization ...